Herbalife Thailand Sponsors Academic Seminar

Food and Healthcare Press Releases Friday June 2, 2017 15:55
Bangkok--2 Jun--Francom Asia

Herbalife, a global nutrition company, in collaboration with the Department of Home Economics, Faculty of Agriculture, Kasetsart University, recently sponsored an academic seminar on the topic "Advances in Metabolic Syndrome". Over 140 participants comprising professors, lecturers and medical students attended this event.

Dr. Chin-Kun Wang, an expert in metabolism and nutrition, is a distinguished professor of the Chung Shan Medical University in Taiwan and member of the Herbalife Nutrition Advisory Board (NAB). He shared the latest research updates and data on Metabolic Syndrome - risk factors for heart disease, stroke and diabetes - in Southeast Asia. He also explained the role of well-balanced nutrition in combating obesity, and addressed health issues associated with the lack of physical activity, unbalanced diets, stressful conditions and other concerns linked with today's demanding lifestyle.

During the seminar, Associate Professor Dr. Sirichai Adisakwattana from Chulalongkorn University's Faculty of Allied Health Sciences, also discussed the prevalence of Metabolic Syndrome in Thai children and adults, and its correlation with obesity and overweight. He shared updates on the government's health policies and strategies such as establishing the Food Innopolis at Thailand Science Park, which is an institution that focuses on research, development and innovation for the food industry.

The most recent data from Thailand's Ministry of Public Health (MOPH) revealed that around 17.4 million Thais (26% of the population) were considered overweight, and that there are twice as many obese women than men. The country is among the top five in Asia-Pacific with the highest numbers of cases of obesity. Moreover, the prevalence of Metabolic Syndrome among Thais aged 15 years and over was 32.1% (16.1 million) overall; 18.6% for men and 45% for women.


Latest Press Release

ESMO Emphasises Importance of Cancer on Global Health Agenda at WHA

At the World Health Assembly in Geneva, ESMO delivered two statements positioning cancer as a priority on the WHO global agenda. (Photo: https://mma.prnewswire.com/media/696385/WHA_Global_Health_Agenda.jpg ) ESMO advocated the strengthening of health...

Real-World Evidence Shows Clinically Meaningful Weight Loss in People Receiving Saxenda(R)

People treated with Saxenda(R) (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. The data were presented this week at both the 25th European...

Venus Medtech#s strategic investment in Keystone Heart deepens the technical layout of cerebral embolic protection market

China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right to exclusively develop, manufacture and sell the 3rd generation...

WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Japan

WCG(TM) (WIRB-Copernicus Group(R)) Clinical Services Division, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the opening of the company's new office in Tokyo, Japan....

Head-to-Head Trial Shows Refixia(R) Achieves Greater Total Factor IX Exposure in People With Haemophilia B Than Recombinant Factor IX-Fc Fusion Protein

Adults with haemophilia B who received a single dose Refixia(R) (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those treated with rFIXFc (recombinant factor IX-Fc fusion protein). The head-to-head paradigm7 trial also observed...

Related Topics